Eugene

[email protected]

LATEST

Teva API Names New President
By

By
Teva Pharmaceutical Industries has appointed John Nason, Teva’s Senior Vice President of European Technical Operations, as President, Teva Active Pharmaceutical Ingredients (TAPI), a role in which he will lead the…

PCI Pharma Services To Acquire Sherpa Clinical Packaging
By

By
PCI Pharma Services (PCI) has agreed to acquire Sherpa Clinical Packaging (Sherpa), a San Diego, California-based provider of clinical-trial supply services. The addition of Sherpa’s capabilities enables PCI to support…

Avara Acquires Sterile Mfg. Facility from Sandoz
By

By
Avara Pharmaceutical Services, a Norwalk, Connecticut-headquartered contract development and manufacturing organization, has acquired Sandoz’s sterile manufacturing facility for injectable medicines in Canada, as part of a continuing expansion of its…

Mylan Buys Two Novartis’ Cystic Fibrosis Products for $463 Million
By

By
Mylan has purchased the worldwide rights to commercialize two of Novartis’ global cystic fibrosis products consisting of TOBI Podhaler (tobramycin inhalation powder) and TOBI solution (tobramycin inhalation solution), for approximately…

Lannett Stops Expansion Plan for New API Plant
By

By
Lannett, a Philadelphia-headquartered generic drug manufacturer, has stopped expansion plans for its active pharmaceutical ingredient (API) manufacturing plant in Cody, Wyoming. Lannett says the decision to stop expansion on the…

FDA Issues Draft Guidance for Post-Market Drug-Substance Manufacturing Changes
By

By
The US Food and Drug Administration (FDA) has published a draft guidance, Postapproval Changes to Drug Substances which discusses how the risk of one or more changes to a drug-substance…

Thermo Fisher Scientific To Acquire Advanced Bioprocessing Business
By

By
Thermo Fisher Scientific has agreed to acquire the advanced bioprocessing business of Becton, Dickinson and Company (BD), a Franklin Lakes, New Jersey-based medical technology company. The bioprocessing business combines a…

Novartis To Sell Portions of Sandoz’s US Business to Aurobindo for $1 Billion
By

By
Novartis has agreed to sell selected portions of its Sandoz US portfolio, specifically the Sandoz US dermatology business and generic US oral solids portfolio, to Aurobindo Pharma USA for $1…

CDMO Ajinomoto Althea Opens New High Potency and Fill/Finish Facility
By

By
Ajinomoto Althea, a San Diego, California-headquartered contract development and manufacturing organization, has opened a new antibody drug conjugate and highly potent fill/finish facility near its existing campus in San Diego. …

Otsuka Partners to Bring Smart Pill to Market
By

By
Otsuka America Pharmaceutical, which received US Food and Drug Administration (FDA) approval for a so-called “smart pill” in 2017, has formed a partnership to support the marketing in the US…